- Home
- / Obalon Therapeutics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Obalon Therapeutics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$3
2021-06-18
Market Capitalization
$30.6 M
2021-06-18
Revenue
$319.7 K
FY, 2025
CreditSafe Score
?
Score changed on Jun 07, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.4M | 9.9M | 9.1M | 3.3M | 1.6M | 13.6M | 11.2M | 8.7M | 8.0M | 319.7K |
| Cost of goods sold | 2.8M | 4.8M | 5.4M | 3.0M | 1.0M | 5.3M | 4.4M | 3.1M | 2.9M | 100.9K |
| Gross profit | 584.0K | 5.1M | 3.7M | 331.0K | 584.0K | 8.3M | 6.8M | 5.5M | 5.1M | 218.8K |
| Gross profit margin, % | 17.2% | 51.3% | 40.4% | 10.1% | 36.8% | 60.5% | 63.2% | 68.4% | ||
| General and administrative expense | 10.2M | 28.8M | 29.9M | 16.7M | 8.8M | 9.2M | 17.3M | 7.5M | 6.9M | 2.4M |
| Operating expense total | 20.1M | 39.5M | 40.6M | 23.6M | 12.5M | 64.8M | 53.2M | 20.9M | 12.8M | 10.7M |
| Depreciation and amortization | 12.0K | |||||||||
| EBIT | (19.5M) | (34.4M) | (37.0M) | (23.2M) | (12.0M) | (56.5M) | (46.4M) | (15.4M) | (7.7M) | (10.5M) |
| EBIT margin, % | -574.9% | -346.9% | -406.2% | -708.0% | -752.6% | -412.4% | -96.5% | -3269.4% | ||
| Interest expense | 477.0K | 135.0K | 226.0K | 385.0K | 29.0K | 113.0K | 26.0K | 14.0K | ||
| Pre tax profit | (62.0M) | (46.6M) | (11.3M) | (7.1M) | ||||||
| Income tax expense | 2.0K | 10.0K | 11.0K | 14.0K | (106.0K) | (380.0K) | 52.0K | 39.0K | ||
| Net Income | (20.5M) | (34.8M) | (37.4M) | (23.7M) | (12.3M) | (61.9M) | (46.2M) | (11.4M) | (7.1M) | (10.5M) |
| EPS | (108.9) | (1.0) | (13.8) | (4.9) |